Abbott Laboratories Stock News

Abbott Laboratories recently became a Dividend King.

Riding The Stock Waves: Update On The Medical Devices Sector

Australian health authorities have recalled several baby formulas by U.S. health care company Abbott Laboratories after reports of four infants getting sick after consuming the formula. Victorian and New South Wales (NSW) doctors issued warnings to parents on Feb. 20, to stop feeding their babies with formula from EleCare, Similac, and Alimentum as they may []

China Customs has warned consumers from buying and eating infant and baby products of Abbott Laboratories, according to said in a post issued on Sunday on its website.

Polen Capital, an investment management firm, published its Polen Focus Growth fourth quarter 2021 investor letter a copy of which can be downloaded here.

Why are investors bullish on DexCom?

SINGAPORE: Abbott Laboratories has been directed to recall certain batches of one of its powdered infant formulas due to the possibility of bacteria, the Singapore Food Agency (SFA) said on Saturday (Feb 19). In a media release, SFA said the company had been told to recall "implicated batches" of

A recall of certain infant formula powders made by Abbott Laboratories (ABT) could cost the company $325M in annual revenue, according to Cowen.

The U.S. Food and Drug Administration (FDA) issued a warning this week about several popular baby formulas made by Abbott Laboratories after reported illnesses across the United States. Chicago-based Abbott Laboratories said it is recalling its Similac, Alimentum, and EleCare formulas that were manufactured in its Sturgis, Michigan, plant, according to a statement posted Thursday. […]

Abbott Laboratories said it is recalling the formula after consumer complaints of bacteria contamination that could cause severe illness in infants.

Abbott Laboratories (NYSE:ABT) declares $0.47/share quarterly dividend, in line with previous.Forward yield 1.62%Payable May 16; for shareholders of record April 15; ex-div April 14.See ABT…

Abbott Laboratories (NYSE: ABT ) recalls powdered baby formulas, including Similac, made at a Michigan facility after four consumers complained about bacterial infections in infants who consumed the products . The complaints were related to Cronobacter sakazakii bacteria or Salmonella Newport. Abbott will also recall its Alimentum and EleCare baby formulas manufactured at the plant in Sturgis. The … Full story available on Benzinga.com

The FDA is urging consumers not to purchase or use certain Similac, Alimentum or EleCare powdered infant formulas produced at Abbott Nutrition's Sturgis, Michigan, facility while it investigates four

Abbott Laboratories (NYSE: ABT) recalls powdered baby formulas, including Similac, made at a Michigan facility after four consumers complained about bacterial infections in infants who consumed the

The FDA is investigating consumer complaints that four babies became sick with bacteria infections after consuming products from Michigan plant